{"id":1609,"date":"2020-12-07T10:53:53","date_gmt":"2020-12-07T09:53:53","guid":{"rendered":"https:\/\/www.paragon.de\/investment\/apontis-pharma\/"},"modified":"2021-01-25T15:02:00","modified_gmt":"2021-01-25T14:02:00","slug":"apontis-pharma","status":"publish","type":"investment","link":"https:\/\/www.paragon.de\/en\/investment\/apontis-pharma\/","title":{"rendered":"APONTIS PHARMA"},"content":{"rendered":"

APONTIS is a leading German supplier of pharmaceuticals for chronically ill patients. Next to co-marketing activities, the company focuses on the development and promotion of single pills and has established itself as a pioneer in this segment. Single pills are a combination of two to three ingredients in one single pill, which has proven to significantly increase adherence and thus patient prognoses compared to the conventional therapy with 2-3 separate pills. APONTIS strong, experienced sales force has direct access to over 24,000 general practitioners in Germany. APONTIS is headquartered in Monheim and employs around 200 people.<\/p>\n","protected":false},"author":5,"featured_media":511,"template":"","class_list":["post-1609","investment","type-investment","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"\nAPONTIS PHARMA - Paragon Partners<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.paragon.de\/en\/investment\/apontis-pharma\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"APONTIS PHARMA - Paragon Partners\" \/>\n<meta property=\"og:description\" content=\"APONTIS is a leading German supplier of pharmaceuticals for chronically ill patients. Next to co-marketing activities, the company focuses on the development and promotion of single pills and has established itself as a pioneer in this segment. Single pills are a combination of two to three ingredients in one single pill, which has proven to … Continued\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.paragon.de\/en\/investment\/apontis-pharma\/\" \/>\n<meta property=\"og:site_name\" content=\"Paragon Partners\" \/>\n<meta property=\"article:modified_time\" content=\"2021-01-25T14:02:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.paragon.de\/wp-content\/uploads\/2020\/12\/Apontis_Bild_806x540px.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"806\" \/>\n\t<meta property=\"og:image:height\" content=\"540\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.paragon.de\/en\/investment\/apontis-pharma\/\",\"url\":\"https:\/\/www.paragon.de\/en\/investment\/apontis-pharma\/\",\"name\":\"APONTIS PHARMA - Paragon Partners\",\"isPartOf\":{\"@id\":\"https:\/\/www.paragon.de\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.paragon.de\/en\/investment\/apontis-pharma\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.paragon.de\/en\/investment\/apontis-pharma\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.paragon.de\/wp-content\/uploads\/2020\/12\/Apontis_Bild_806x540px.jpg\",\"datePublished\":\"2020-12-07T09:53:53+00:00\",\"dateModified\":\"2021-01-25T14:02:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.paragon.de\/en\/investment\/apontis-pharma\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.paragon.de\/en\/investment\/apontis-pharma\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.paragon.de\/en\/investment\/apontis-pharma\/#primaryimage\",\"url\":\"https:\/\/www.paragon.de\/wp-content\/uploads\/2020\/12\/Apontis_Bild_806x540px.jpg\",\"contentUrl\":\"https:\/\/www.paragon.de\/wp-content\/uploads\/2020\/12\/Apontis_Bild_806x540px.jpg\",\"width\":806,\"height\":540},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.paragon.de\/en\/investment\/apontis-pharma\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.paragon.de\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"APONTIS PHARMA\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.paragon.de\/#website\",\"url\":\"https:\/\/www.paragon.de\/\",\"name\":\"Paragon Partners\",\"description\":\"Beteiligungsgesellschaft M\u00fcnchen\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.paragon.de\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"APONTIS PHARMA - Paragon Partners","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.paragon.de\/en\/investment\/apontis-pharma\/","og_locale":"en_US","og_type":"article","og_title":"APONTIS PHARMA - Paragon Partners","og_description":"APONTIS is a leading German supplier of pharmaceuticals for chronically ill patients. Next to co-marketing activities, the company focuses on the development and promotion of single pills and has established itself as a pioneer in this segment. Single pills are a combination of two to three ingredients in one single pill, which has proven to … Continued","og_url":"https:\/\/www.paragon.de\/en\/investment\/apontis-pharma\/","og_site_name":"Paragon Partners","article_modified_time":"2021-01-25T14:02:00+00:00","og_image":[{"width":806,"height":540,"url":"https:\/\/www.paragon.de\/wp-content\/uploads\/2020\/12\/Apontis_Bild_806x540px.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.paragon.de\/en\/investment\/apontis-pharma\/","url":"https:\/\/www.paragon.de\/en\/investment\/apontis-pharma\/","name":"APONTIS PHARMA - Paragon Partners","isPartOf":{"@id":"https:\/\/www.paragon.de\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.paragon.de\/en\/investment\/apontis-pharma\/#primaryimage"},"image":{"@id":"https:\/\/www.paragon.de\/en\/investment\/apontis-pharma\/#primaryimage"},"thumbnailUrl":"https:\/\/www.paragon.de\/wp-content\/uploads\/2020\/12\/Apontis_Bild_806x540px.jpg","datePublished":"2020-12-07T09:53:53+00:00","dateModified":"2021-01-25T14:02:00+00:00","breadcrumb":{"@id":"https:\/\/www.paragon.de\/en\/investment\/apontis-pharma\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.paragon.de\/en\/investment\/apontis-pharma\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.paragon.de\/en\/investment\/apontis-pharma\/#primaryimage","url":"https:\/\/www.paragon.de\/wp-content\/uploads\/2020\/12\/Apontis_Bild_806x540px.jpg","contentUrl":"https:\/\/www.paragon.de\/wp-content\/uploads\/2020\/12\/Apontis_Bild_806x540px.jpg","width":806,"height":540},{"@type":"BreadcrumbList","@id":"https:\/\/www.paragon.de\/en\/investment\/apontis-pharma\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.paragon.de\/en\/"},{"@type":"ListItem","position":2,"name":"APONTIS PHARMA"}]},{"@type":"WebSite","@id":"https:\/\/www.paragon.de\/#website","url":"https:\/\/www.paragon.de\/","name":"Paragon Partners","description":"Beteiligungsgesellschaft M\u00fcnchen","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.paragon.de\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.paragon.de\/en\/wp-json\/wp\/v2\/investment\/1609","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.paragon.de\/en\/wp-json\/wp\/v2\/investment"}],"about":[{"href":"https:\/\/www.paragon.de\/en\/wp-json\/wp\/v2\/types\/investment"}],"author":[{"embeddable":true,"href":"https:\/\/www.paragon.de\/en\/wp-json\/wp\/v2\/users\/5"}],"version-history":[{"count":5,"href":"https:\/\/www.paragon.de\/en\/wp-json\/wp\/v2\/investment\/1609\/revisions"}],"predecessor-version":[{"id":2473,"href":"https:\/\/www.paragon.de\/en\/wp-json\/wp\/v2\/investment\/1609\/revisions\/2473"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.paragon.de\/en\/wp-json\/wp\/v2\/media\/511"}],"wp:attachment":[{"href":"https:\/\/www.paragon.de\/en\/wp-json\/wp\/v2\/media?parent=1609"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}